Virologic response is not durable after adefovir discontinuation in lamivudine-resistant chronic hepatitis B patients-Reference-Cited by-同舟云学术

Virologic response is not durable after adefovir discontinuation in lamivudine-resistant chronic hepatitis B patients

Published:2011 Issue:4 Volume:17 Page:261
ISSN:1738-222X
Container-title:The Korean Journal of Hepatology
language:en
Short-container-title:Korean J Hepatol

Author:

Jung Young Kul¹²,Yeon Jong Eun¹,Lee Kwang Gyun³,Jung Eun Seok¹,Kim Jeong Han⁴,Kim Ji Hoon¹,Seo Yeon Seok³,Yim Hyung Joon⁴,Um Sun Ho³,Ryu Ho Sang³,Byun Kwan Soo¹

Affiliation:

1. Department of Internal Medicine, Korea University Guro Hospital, Seoul, Korea.

2. Department of Internal Medicine, Gachon University Gil Hospital, Gachon University of Medicine and Science, Incheon, Korea.

3. Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.

4. Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Seoul, Korea.

Publisher

The Korean Association for the Study of the Liver

Subject

General Medicine

Link

http://synapse.koreamed.org/pdf/10.3350/kjhep.2011.17.4.261

Reference25 articles.

1. Long-Term Therapy with Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B

2. Chronic hepatitis B

3. Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

4. Sustained Hepatitis B e Antigen Seroconversion in Patients with Chronic Hepatitis B after Adefovir Dipivoxil Treatment: Analysis of Precore and Basal Core Promoter Mutants

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic review: Clinical outcomes of discontinuation of oral antivirals in hepatitis B-related liver cirrhosis;Frontiers in Public Health;2022-11-03

2. Challenges in the discontinuation of chronic hepatitis B antiviral agents;World Journal of Hepatology;2021-09-27

3. Risks and Benefits of Discontinuation of Nucleos(t)ide Analogue Treatment: A Treatment Concept for Patients With HBeAg‐Negative Chronic Hepatitis B;Hepatology Communications;2021-06-18

4. Perspectives on stopping nucleos(t)ide analogues therapy in patients with chronic hepatitis B;Antiviral Research;2021-01

5. Is it possible to stop nucleos(t)ide analogue treatment in chronic hepatitis B patients?;World Journal of Gastroenterology;2018-05-07